Peter Moldt is listed as a director on 27 SEC Form D filings by 11 issuers between Dec 2011 and Oct 2023. Largest by amount reported sold: Avalyn Pharma Inc. (Seattle, WA — biotechnology — 2023; $189.2M reported sold to 46 investors), Aligos Therapeutics, Inc. (South San Francisco, CA — biotechnology — 2020; $105M reported sold to 38 investors), Swift Health Systems Inc. (Irvine, CA — other health care — 2019–2021; $102M reported sold to 26 investors), Allakos Inc. (San Carlos, CA — biotechnology — 2012–2015; $100.1M reported sold to 40 investors), Bolt Biotherapeutics, Inc. (Redwood City, CA — biotechnology — 2016–2021; $93.5M reported sold to 17 investors) and 6 more (all listed below).
What this means That is a lot of deals — 11 separate companies raised money with this person listed as director, over about 12 years. Across those companies the filings report $879.4M sold in total.
Listed alongside Peter A. Thompson (6 shared filings), Asish Xavier (5 shared filings), Bruce Montgomery (5 shared filings, management entity), Edgar Engleman (5 shared filings), John P. McKearn (5 shared filings) and 87 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Peter. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 1 bankruptcy case matching the name listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 27 public filings for Peter Moldt and found 18 differences, 2 worth asking the sponsor about: Investor count went down between filings; 100% of the money raised went to insiders; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.